Worst Medical Patent of the Century?

Most medical patents help you get healthier and as a medical device patent attorney, I take a special interest in news and commentary relating to medical and dental patents.  I came across this one medical patent, however, that allegedly killed thousands of people, many of them women and children.

Imagine the following scenario...

You step onto a harmless looking machine. On top of the machine are three viewing ports. One for you. One for your mother. And one for the clueless machine operator. With the push of a button, all three of you are exposed to 20 to 45 seconds of radiation.

To put that into perspective, today's x-rays only last long enough to take a picture...usually less than a second.

The result? Birth defects, tumors, cancer and death.

Does that sound like a horrible Nazi experiment? Well it's not. It's actually occurred in thousands of shoe stores across the United States did from the 1930's to 1950's. You read that right...shoe stores.

Dangerous Use of a Worthwhile Medical Patent

x ray patentThe medical device is called a shoe fitting fluoroscope. It used radiation to produce an x-ray of the foot inside a shoe (to help in fitting). The three viewing ports on the top of the cabinet would allow you to see a fluorescent image of the bones of the feet and the outline of the shoes.

Used mainly as a gimmicky marketing tool, it was a common fixture in shoe stores during the 1930s, 1940s and 1950s. A typical unit, like the Adrian machine shown here, consisted of a vertical wooden cabinet with an opening near the bottom into which the feet were placed.

Most units also had a push button timer that could be set to a desired exposure time. The most common setting was 20 seconds.

Medical Patent Worst for Operator

A 20 second dose of low level radiation won't kill you. But multiple doses every day for a few years will. This patented machine wasn't nearly as dangerous to the customer as it was for the shoe salesman.

patent ad

Ad for the Fluoroscope Shoe Fitting Machine

For example, to show how a shoe fit many salesperson would put their hands into the x-ray beam to squeeze the shoe during the fitting. As a result, one saleswoman who had operated a shoe fitting fluoroscope 10 to 20 times each day over a ten year period developed dermatitis of the hands.

One of the more serious injuries linked to the operation of these machines involved a shoe model who received such a serious radiation burn that her leg had to be amputated.

This is one medical patent that goes down amongst the worst of the century.

Sources for this patent story:

Shoe Fitting Fluoroscope 

Wikipedia 

Museum of Quakery 

Medical Patent News of the Week

As a medical device patent attorney, I take a special interest in news and commentary relating to medical patents, dental patents, and related technology.  In this regard, below is a recap of medical patent news for the week:

Five Medical Patent Applications for Lymphoma

MMRGlobal filed five patent applications to treat lymphoma. They include protection for anti-CD20 antibodies, methods of treating B-cell lymphomas using anti-CD20 antibodies, manufacturing methods for idiotype vaccines to treat B-cell pathologies, methods for treating B-cell malignancies with vaccines, and methods for using the vaccines as combinational therapies with chemotherapeutic agents. They’ve also been issued a patent for methods of treating B-cell mediated malignancies.

Read the full story here – Patent Applications

Medical Patent Spat Resolved

patent lawsuitMicroAire Surgical Instruments LLC settled a patent infringement and breach of contract lawsuit with Arthrex Inc. involving minimally invasive treatment for carpal tunnel syndrome. Charlottesville, Va.-based MicroAire sued Naples, Fla.-based Arthrex over claims related to the technology, an alternative to open-hand surgery.

Read the full story here – Patent Dispute

Bovie Medical Patents Push Share Price Up

Shares of Bovie Medical Corporation, shot up more than 53% after the manufacturer and marketer of electrosurgical products announced new patents. They also recently submitted an application with the Food and Drug Administration (FDA) to market a new handpiece with retractable cutting features to be used in both laparoscopic and open procedures. On November 8, 2010 Bovie filed additional patents for its new J-Plasma handpiece.

Read the full story here – Medical Patent

Doctor Patents Medical Device to Curb Hospital Infections

Richard H. Ma, M.D has received a patent for a lightweight plastic cover for stethoscopes that will dramatically reduce hospital-acquired infections. Stethguard is a V-shaped clear plastic cover that protects the head of the stethoscope up to its neck, where most of the germs and bacteria are located.

Read the full story here – Medical Device Patent

U.S. Supreme Court to decide Stanford University patent case

The U.S. Supreme Court on Monday agreed to consider Stanford University's quest to assert the patent rights of its medical researchers, setting up a legal showdown between the nation's federally funded academic research arms and one of the world's pharmaceutical giants.

Read the full story here – Medical Patent Case

Judge Nixes Medical Patent

wake forest patentA Texas judge has struck down the patent protection behind a key medical device technology that has been worth hundreds of millions of dollars to Wake Forest University through the years. Called “Vacuum-Assisted Closure”, it helps to close off a wound promoting faster healing.

Read the full story here - Medical Device Patent Struck Down

Medicine, drugs, genes and the death of a patent niche?

Inventors pursuing medical patents involving genes should listen to this...

On October 29th, the federal government reversed a longstanding policy by saying that humanpatent dna genes are part of nature and therefore cannot be patented. While the U.S. Patent and Trademark Office is not changing its rules for the time being, this decision may reverse the nearly 30 year old legal precedent of patenting parts of nature.

It all started with a March 29th decision by a Judge Robert W. Sweet that invalidated seven patents related to the genes BRCA1 and BRCA2, whose mutations have been associated with cancer.

The patents were held by Myriad Genetics and the University of Utah Research Foundation, who charged $3,000 to perform tests on women to determine whether or not BRCA1 or BRCA2 genes would lead to mutations which could lead to breast and ovarian cancers. 

You Can't Patent "Natural"

 The main argument in this medical patent case is what is natural and what is not. The government claims that since genes are natural, you can patent them any more than you could patent an apple. A government brief from this case states:

"the chemical structure of native human genes is a product of nature, and it is no less a product of nature when that structure is ‘isolated' from its natural environment than are cotton fibers that have been separated from cotton seeds or coal that has been extracted from the earth."

Government critics are singing a different tune...

Long Term Innovation Hampered by No Patent Ruling?

dna patent research

 Critics claim the government's anti-patent view of genes will put people in danger. Denying patents – they say – will hamper experimentation and development of diagnostic tests and drugs to treat specific genes. The long term implications being less treatment options for people with rare diseases.

The government insists prohibiting patents on parts of nature would not adversely affect the medical or biotechnology industry. And patents for man-made manipulations to DNA could still be approved.

Who is right? Only time will tell.

Sources for this article:

NPR - Feds Surprise Biotech Industry With Gene Patent Rule

NY Times - Judge Invalidates Human Gene Patent

NY Times - U.S. Says Genes Should Not Be Eligible for Patents